Markets:

Overview

News

Currencies

International

Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.2347 -0.0053 (-2.21%)

Streaming Delayed Price Updated: 2:44 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today? ↗

April 16, 2024

Calidi Biotherapeutics stock is falling hard on Tuesday after the company priced a public offering for more than 15 million shares of CLDI.

Via InvestorPlace

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

April 16, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

April 16, 2024

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 16, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 16, 2024

Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them!

Via InvestorPlace

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024

April 09, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023 ↗

March 15, 2024

CLDI stock results show that Calidi Biotherapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

March 15, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

March 11, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 12, 2024

Via Benzinga

Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference

February 12, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 30, 2024

Via Benzinga

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 22, 2024

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the...

Via Benzinga

Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2024

Shares of Juniper Networks, Inc. (NYSE: JNPR) rose sharply in pre-market trading on Tuesday.

Via Benzinga

Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board

January 08, 2024

From Calidi Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 03, 2024

Via Benzinga

Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket ↗

January 03, 2024

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 03, 2024

It's time to dive into the biggest pre-market stock movers with all of the latest coverage worth reading about on Wednesday morning!

Via InvestorPlace

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

December 13, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Appointment of Pharmaceutical Industry Veteran David LaPré to its Board of Directors

December 12, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones

November 20, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results

November 14, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics (NYSEAM: CLDI) Presents Data on CLD-201 Demonstrating Inhibition of Tumor Growth and Induction of Robust Anti-Tumor Immunity at the Society for Immunotherapy of Cancer’s 38th Annual Meeting (SITC 2023)

November 03, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Key Leadership Promotions and New Board Appointment

November 01, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

Calidi Biotherapeutics Announces Appointment of Andrew Jackson as Chief Financial Officer

October 30, 2023

From Calidi Biotherapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.